EGFR L858R + VOPP1-EGFR fusion + EGFR T790M
|
NSCLC
|
EGFR L858R + VOPP1-EGFR fusion + EGFR T790M
|
NSCLC
|
osimertinib Sensitive: C4 – Case Studies
|
osimertinib Sensitive: C4 – Case Studies
|
EGFR L858R + VOPP1-EGFR fusion + EGFR T790M
|
NSCLC
|
EGFR L858R + VOPP1-EGFR fusion + EGFR T790M
|
NSCLC
|
icotinib Resistant: C4 – Case Studies
|
icotinib Resistant: C4 – Case Studies
|